CUBIST PHARMACEUTICALS INC — Operating Income by Fiscal Year
6 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/22fbfe46-3e98-4089-9e9d-e873b35dfe23/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2013 | $26.4M | 2013-01-01 – 2013-12-31 | evidence 0001047469-14-001280 |
| FY 2012 | $237.1M | 2012-01-01 – 2012-12-31 | evidence 0001047469-13-001765 |
| FY 2011 | $132.5M | 2011-01-01 – 2011-12-31 | evidence 0001047469-12-001597 |
| FY 2010 | $189.6M | 2010-01-01 – 2010-12-31 | evidence 0001047469-11-001194 |
| FY 2009 | $137.8M | 2009-01-01 – 2009-12-31 | evidence 0001047469-11-001194 |
| FY 2008 | $90.9M | 2008-01-01 – 2008-12-31 | evidence 0001047469-11-001194 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).